Aldeyra Therapeutics Inc (NASDAQ: ALDX) kicked off on Monday, down -12.11% from the previous trading day, before settling in for the closing price of $4.54. Over the past 52 weeks, ALDX has traded in a range of $1.14-$7.20.
During the last 5-year period, the sales growth of Healthcare Sector giant was 15.99%. While this was happening, its average annual earnings per share was recorded 34.84%. With a float of $58.21 million, this company’s outstanding shares have now reached $60.16 million.
Aldeyra Therapeutics Inc (ALDX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Aldeyra Therapeutics Inc is 3.24%, while institutional ownership is 65.69%. The most recent insider transaction that took place on Aug 13 ’25, was worth 13,250. In this transaction Principal Financial Officer of this company bought 2,500 shares at a rate of $5.30, taking the stock ownership to the 2,500 shares. Before that another transaction happened on Aug 11 ’25, when Company’s Chief Development Officer sold 22,073 for $5.15, making the entire transaction worth $113,713. This insider now owns 221,799 shares in total.
Aldeyra Therapeutics Inc (ALDX) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.27 earnings per share (EPS), lower than consensus estimate (set at -0.22) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.84% per share during the next fiscal year.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Trading Performance Indicators
Take a look at Aldeyra Therapeutics Inc’s (ALDX) current performance indicators. Last quarter, stock had a quick ratio of 2.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.72, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.13 in one year’s time.
Technical Analysis of Aldeyra Therapeutics Inc (ALDX)
Looking closely at Aldeyra Therapeutics Inc (NASDAQ: ALDX), its last 5-days average volume was 1.56 million, which is a jump from its year-to-date volume of 1.06 million. As of the previous 9 days, the stock’s Stochastic %D was 2.90%.
During the past 100 days, Aldeyra Therapeutics Inc’s (ALDX) raw stochastic average was set at 0.91%, which indicates a significant decrease from 1.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.31 in the past 14 days, which was higher than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.11, while its 200-day Moving Average is $4.51. However, in the short run, Aldeyra Therapeutics Inc’s stock first resistance to watch stands at $4.47. Second resistance stands at $4.95. The third major resistance level sits at $5.20. If the price goes on to break the first support level at $3.74, it is likely to go to the next support level at $3.49. Should the price break the second support level, the third support level stands at $3.01.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Key Stats
The company with the Market Capitalisation of 240.05 million has total of 60,163K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -55,850 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -7,690 K.
